Drug price review to raise unbearable tensions to drug industries.

Published: 2006-10-16 07:00:00

Updated: 2006-10-16 07:00:00

A stormy aftermath of the 2006 government's drug price review may batter the drug industry with unbearable tensions, viewing that unlike the past reviews this year it included big seller products and large volumes.

The Health Insurance Review Agency (HIRA) disclosed "2006 regular drug price re...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK